ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 185 filers reported holding ACCELERON PHARMA INC in Q4 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $756,000 | -97.0% | 4,392 | -97.8% | 0.05% | -96.9% |
| Q2 2021 | $25,098,000 | +15.7% | 200,000 | +25.0% | 1.70% | +12.6% |
| Q1 2021 | $21,698,000 | +6.0% | 160,000 | 0.0% | 1.51% | -9.4% |
| Q4 2020 | $20,470,000 | +25.5% | 160,000 | +10.3% | 1.67% | +15.1% |
| Q3 2020 | $16,317,000 | +10.5% | 145,000 | -6.5% | 1.45% | -9.0% |
| Q2 2020 | $14,767,000 | +134.7% | 155,000 | +121.4% | 1.60% | +81.0% |
| Q1 2020 | $6,291,000 | +18.7% | 70,000 | -30.0% | 0.88% | +51.6% |
| Q4 2019 | $5,302,000 | +91.7% | 100,000 | +42.9% | 0.58% | +67.4% |
| Q3 2019 | $2,766,000 | -3.8% | 70,000 | 0.0% | 0.35% | +9.5% |
| Q2 2019 | $2,876,000 | -11.8% | 70,000 | 0.0% | 0.32% | -16.8% |
| Q1 2019 | $3,260,000 | – | 70,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |